This company seems to have been delisted
Reason: Failure to Satisfy a Continued Listing Rule or Standard
Last recorded trade on: April 18, 2025
Source: https://www.sec.gov/Archives/edgar/data/1166272/000149315224049733/ex99-1.htm
Reason: Failure to Satisfy a Continued Listing Rule or Standard
Last recorded trade on: April 18, 2025
Source: https://www.sec.gov/Archives/edgar/data/1166272/000149315224049733/ex99-1.htm
Genetic Technologies
GENE
S$0.98
Share price
0.00%
Change (1 day)
-69.92%
Change (1 year)
Categories
Genetic Technologies (GENE) - Cash on Hand
Cash on Hand as of June 2024 : S$0.87 Million
According to Genetic Technologies's latest financial reports the company has S$0.87 Million in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Genetic Technologies - Cash on Hand chart (from 2004 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-06-30 | S$0.92 M | -86.83% |
| 2023-06-30 | S$7.02 M | -37.37% |
| 2022-06-30 | S$11.22 M | -46.87% |
| 2021-06-30 | S$21.11 M | 55.14% |
| 2020-06-30 | S$13.61 M | 572.74% |
| 2019-06-30 | S$2.02 M | -63.47% |
| 2018-06-30 | S$5.53 M | -52.36% |
| 2017-06-30 | S$11.62 M | 3.33% |
| 2016-06-30 | S$11.25 M | -40.66% |
| 2015-06-30 | S$18.96 M | 470.01% |
| 2014-06-30 | S$3.32 M | 48.59% |
| 2013-06-30 | S$2.23 M | -80.65% |
| 2012-06-30 | S$11.57 M | 72.69% |
| 2011-06-30 | S$6.7 M | 73.5% |
| 2010-06-30 | S$3.86 M | -57.62% |
| 2009-06-30 | S$9.11 M | -47.98% |
| 2008-06-30 | S$17.52 M | 1.2% |
| 2007-06-30 | S$17.31 M | 37.49% |
| 2006-06-30 | S$12.59 M | -44.8% |
| 2005-06-30 | S$22.81 M | 69.97% |
| 2004-06-30 | S$13.42 M | 88.79% |
| 2003-06-30 | S$7.1 M | 0.08% |
| 2002-06-30 | S$7.1 M | 1078.37% |
| 2001-06-30 | S$0.6 M | -52.81% |
| 2000-06-30 | S$1.27 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Eterna Therapeutics ERNA | S$2.46 M | 180.78% | 🇺🇸 USA |
 Myriad Genetics MYGN | S$0.11 B | 13,338.87% | 🇺🇸 USA |
 LabCorp LH | S$0.47 B | 53,977.56% | 🇺🇸 USA |
 Quest Diagnostics
DGX | S$0.24 B | 27,421.87% | 🇺🇸 USA |
 Compugen CGEN | S$0.13 B | 15,087.54% | 🇮🇱 Israel |
 Danaher DHR | S$2.56 B | 291,661.15% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | S$7.65 B | 870,498.88% | 🇺🇸 USA |
 Neogen NEOG | S$0.16 B | 18,595.11% | 🇺🇸 USA |